Promoter Essix Biosciences converts 14 lakh warrants into equity shares

Promoter Stake BuyPromoter Below 50pctOwnership Changes View source PDF Explain this filing

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹362.00

prior close

₹363.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.2% vs market

Pharmaceuticals peers, median of 168sector-0.3%+0.3% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.8

10m

-3.2

15m

-3.4

30m

-3.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.2-0.2-0.3+0.3

Next day

+2.1+0.9+1.2-0.3+2.4

-1.4-0.8-0.6-1.2-0.2

-0.9-0.1-0.8-1.0+0.1

-3.3-1.7-1.6-2.6-0.7

-5.4-4.3-1.1-3.8-1.6

-9.4-7.5-1.9-6.4-3.0

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Essix Biosciences, part of the promoter group of Ind-Swift Laboratories, converted 14,00,000 fully convertible warrants into equity shares on October 8, 2026 through a preferential issue. Essix Biosciences stake rose from 37.81% to 38.80% of total equity. Total promoter group holding stands at 43.84% of share capital and 47.18% on diluted basis.

Likely market impact

Promoter group stake rises by about 1.58% via warrant conversion. Minor dilution for non-promoters but signals promoter commitment.